These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 17942929)
1. Thymic stromal-derived lymphopoietin induces proliferation of pre-B leukemia and antagonizes mTOR inhibitors, suggesting a role for interleukin-7Ralpha signaling. Brown VI; Hulitt J; Fish J; Sheen C; Bruno M; Xu Q; Carroll M; Fang J; Teachey D; Grupp SA Cancer Res; 2007 Oct; 67(20):9963-70. PubMed ID: 17942929 [TBL] [Abstract][Full Text] [Related]
2. A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis. Francis OL; Milford TA; Martinez SR; Baez I; Coats JS; Mayagoitia K; Concepcion KR; Ginelli E; Beldiman C; Benitez A; Weldon AJ; Arogyaswamy K; Shiraz P; Fisher R; Morris CL; Zhang XB; Filippov V; Van Handel B; Ge Z; Song C; Dovat S; Su RJ; Payne KJ Haematologica; 2016 Apr; 101(4):417-26. PubMed ID: 26611474 [TBL] [Abstract][Full Text] [Related]
3. Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling. Rochman Y; Kashyap M; Robinson GW; Sakamoto K; Gomez-Rodriguez J; Wagner KU; Leonard WJ Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19455-60. PubMed ID: 20974963 [TBL] [Abstract][Full Text] [Related]
4. Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. Levin SD; Koelling RM; Friend SL; Isaksen DE; Ziegler SF; Perlmutter RM; Farr AG J Immunol; 1999 Jan; 162(2):677-83. PubMed ID: 9916685 [TBL] [Abstract][Full Text] [Related]
5. TSLP or IL-7 provide an IL-7Rα signal that is critical for human B lymphopoiesis. Milford TA; Su RJ; Francis OL; Baez I; Martinez SR; Coats JS; Weldon AJ; Calderon MN; Nwosu MC; Botimer AR; Suterwala BT; Zhang XB; Morris CL; Weldon DJ; Dovat S; Payne KJ Eur J Immunol; 2016 Sep; 46(9):2155-61. PubMed ID: 27325567 [TBL] [Abstract][Full Text] [Related]
6. TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia. Alkashgari HR; Ruiz-Jimenez C; Stoian C; Coats JS; Baez I; Chirshev E; Martinez SR; Dovat S; Francis-Boyle OL; Casiano CA; Payne KJ Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613920 [TBL] [Abstract][Full Text] [Related]
7. Thymic stromal lymphopoietin induces early human B-cell proliferation and differentiation. Scheeren FA; van Lent AU; Nagasawa M; Weijer K; Spits H; Legrand N; Blom B Eur J Immunol; 2010 Apr; 40(4):955-65. PubMed ID: 20127673 [TBL] [Abstract][Full Text] [Related]
8. Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. Isaksen DE; Baumann H; Trobridge PA; Farr AG; Levin SD; Ziegler SF J Immunol; 1999 Dec; 163(11):5971-7. PubMed ID: 10570284 [TBL] [Abstract][Full Text] [Related]
12. BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3. Nakayama J; Yamamoto M; Hayashi K; Satoh H; Bundo K; Kubo M; Goitsuka R; Farrar MA; Kitamura D Blood; 2009 Feb; 113(7):1483-92. PubMed ID: 19047679 [TBL] [Abstract][Full Text] [Related]
13. Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation. Quentmeier H; Drexler HG; Fleckenstein D; Zaborski M; Armstrong A; Sims JE; Lyman SD Leukemia; 2001 Aug; 15(8):1286-92. PubMed ID: 11480573 [TBL] [Abstract][Full Text] [Related]
14. Identification of amino acids in transmembrane domains of mutated cytokine receptor-like factor 2 and interleukin-7 receptor α required for constitutive signal transduction. Yamamoto R; Segawa R; Kato H; Niino Y; Sato T; Hiratsuka M; Hirasawa N Biochim Biophys Acta Biomembr; 2024 Oct; 1866(7):184359. PubMed ID: 38862034 [TBL] [Abstract][Full Text] [Related]
15. Uncoupling of proliferation and Stat5 activation in thymic stromal lymphopoietin-mediated signal transduction. Isaksen DE; Baumann H; Zhou B; Nivollet S; Farr AG; Levin SD; Ziegler SF J Immunol; 2002 Apr; 168(7):3288-94. PubMed ID: 11907084 [TBL] [Abstract][Full Text] [Related]
16. Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2. van Bodegom D; Zhong J; Kopp N; Dutta C; Kim MS; Bird L; Weigert O; Tyner J; Pandey A; Yoda A; Weinstock DM Blood; 2012 Oct; 120(14):2853-63. PubMed ID: 22915648 [TBL] [Abstract][Full Text] [Related]
17. Activation of the mTOR signalling pathway is required for pancreatic growth in protease-inhibitor-fed mice. Crozier SJ; Sans MD; Guo L; D'Alecy LG; Williams JA J Physiol; 2006 Jun; 573(Pt 3):775-86. PubMed ID: 16613881 [TBL] [Abstract][Full Text] [Related]
18. LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors. Cheng Y; Chikwava K; Wu C; Zhang H; Bhagat A; Pei D; Choi JK; Tong W J Clin Invest; 2016 Apr; 126(4):1267-81. PubMed ID: 26974155 [TBL] [Abstract][Full Text] [Related]
20. Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin. Ly C; Arechiga AF; Melo JV; Walsh CM; Ong ST Cancer Res; 2003 Sep; 63(18):5716-22. PubMed ID: 14522890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]